European Radiology · 2016 · 72 citations · 37 references
MedicineOncologyRadiologyBiomedical ImagingBreast OncologyDiagnostic ImagingBreast Cancer ImagingBreast ImagingNeoadjuvant ChemotherapyNeoadjuvant TherapyTherapy Response AssessmentTumor ImagingBreast Cancer Response AssessmentDiffusion CoefficientsDiffusion Mri ModelingEarly Treatment Response AssessmentEarly Treatment Response PredictionImaging Response EvaluationTissue DiffusionTumor Diffusion Imaging
To assess the feasibility of the mono-exponential, bi-exponential and stretched-exponential models in evaluating response of breast tumours to neoadjuvant chemotherapy (NACT) at 3 T. Thirty-six female patients (median age 53, range 32–75 years) with invasive breast cancer undergoing NACT were enrolled for diffusion-weighted MRI (DW-MRI) prior to the start of treatment. For assessment of early response, changes in parameters were evaluated on mid-treatment MRI in 22 patients. DW-MRI was performed using eight b values (0, 30, 60, 90, 120, 300, 600, 900 s/mm2). Apparent diffusion coefficient (ADC), tissue diffusion coefficient (D t), vascular fraction (ƒ), distributed diffusion coefficient (DDC) and alpha (α) parameters were derived. Then t tests compared the baseline and changes in parameters between response groups. Repeatability was assessed at inter- and intraobserver levels. All patients underwent baseline MRI whereas 22 lesions were available at mid-treatment. At pretreatment, mean diffusion coefficients demonstrated significant differences between groups (p < 0.05). At mid-treatment, percentage increase in ADC and DDC showed significant differences between responders (49 % and 43 %) and non-responders (21 % and 32 %) (p = 0.03, p = 0.04). Overall, stretched-exponential parameters showed excellent repeatability. DW-MRI is sensitive to baseline and early treatment changes in breast cancer using non-mono-exponential models, and the stretched-exponential model can potentially monitor such changes. • Baseline diffusion coefficients demonstrated significant differences between complete pathological responders and non-responders. • Increase in ADC and DDC at mid-treatment can discriminate responders and non-responders. • The ƒ fraction at mid-treatment decreased in responders whereas increased in non-responders. • The mono- and stretched-exponential models showed excellent inter- and intrarater repeatability. • Treatment effects can potentially be assessed by non-mono-exponential diffusion models.
37
Aron Goldhirsch, W. C. Wood, Alan S. Coates et al. · Annals of Oncology · 2011 · 3.9K citations · Full text
Medicine, Oncology, Breast Oncology +16
Denis Le Bihan, D Lallemand, P. Grenier et al. · Radiology · 1986 · 3.9K citations
Harry D. Bear, Stewart Anderson, Roy E. Smith et al. · Journal of Clinical Oncology · 2006 · 948 citations · Full text